(Q35863417)

10 August 2017

1 reference

title

Functional imaging in Parkinson's disease and dementia with Lewy bodies (English)

1 reference

10 August 2017

1 reference

1 reference

John O'Brien

2

0 references

author name string

Sean Colloby

series ordinal

1

1 reference

10 August 2017

publication date

1 September 2004

1 reference

Journal of Geriatric Psychiatry and Neurology

10 August 2017

published in

1 reference

10 August 2017

volume

17

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

158-163

1 reference

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane in patients with movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

[(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Cognitive function and regional cerebral blood flow in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Regional cerebral blood flow in Parkinson's disease with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Beta-CIT-SPECT combined with UPDRS appears to distinguish different parkinsonian conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Imaging of D2 dopamine receptors of patients with Parkinson's disease using single photon emission computed tomography and iodobenzamide I 123.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Neural basis for impaired time reproduction in Parkinson's disease: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Regional cerebral blood flow difference between dementia with Lewy bodies and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Proton magnetic resonance spectroscopy in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Extrastriatal dopamine D(2) receptors in Parkinson's disease: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267468

21 January 2018

Identifiers

DOI

10.1177/0891988704267468

1 reference

10 August 2017

1 reference